Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing

HONG KONG, Dec 9, 2022 - (ACN Newswire via SEAPRWire.com) - Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as "GS Biotech") officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital. The proceeds will be mainly used for the capacity expansion…

Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round

HONG KONG, Oct 20, 2022 - (ACN Newswire via SEAPRWire.com) - VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. The proceeds will facilitate VectorBuilder in continuously promoting…

The Next Vision Capital Announces an Investment from IDG Capital Blockchain

Hanoi, Vietnam, October 17, 2022 – (SEAPRWire) – Recently, the Next Vision Capital, a digital financial platform offering packages to SMEs, is proud to announce an Investment from IDG Capital Blockchain (IDGCB). IDG Capital Blockchain currently manages 40 million dollars and has been investing in over 30 companies under various sectors. Having found the potential of…

AIM Vaccine, a Major Player in the Chinese Vaccine Industry Successfully Listed on the Main Board of SEHK

HONG KONG, Oct 6, 2022 - (ACN Newswire via SEAPRWire.com) - AIM Vaccine Co., Ltd. ("AIM Vaccine" or the "Company", together with its subsidiaries, the "Group", stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), was successfully listed…

My Platform Joint Venture Awarded the Winner’s Prize in the 2022 Hong Kong-Macau-Taiwan Innovation and Entrepreneurship Competition

HONG KONG, Sep 29, 2022 - (ACN Newswire via SEAPRWire.com) - My Platform, the MedTech venture in which Black Spade Capital Limited ("Black Spade Capital") invested, has just announced that its PRC joint venture My Platform Information Technology (Guangzhou) Limited ("My Platform MedTech") was awarded the Winner's Prize in the…

GalaxySpace Completes a New Financing Round with Legend Capital Re-upped

HONG KONG, Sep 25, 2022 - (ACN Newswire via SEAPRWire.com) - GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. As an existing shareholder, Legend Capital continued to support the company by following up on this financing round.Legend Capital…

TR Capital Positions Firm to Capture Tremendous Growth Opportunity in Southeast Asia with New Singapore Office

SINGAPORE, Sep 16, 2022 - (ACN Newswire via SEAPRWire.com) - TR Capital, the leading Asian secondary private equity firm, today announced the opening of its fifth office in the APAC region, and the firm's Southeast Asia Headquarters, in Singapore. Paul Robine, Founder and CEO of TR Capital, said, "We see…

Leading VC Firm, Black3Lab Capital Announces Investment in Ripe Web 3.0 Sectors

New York, NY, September 02, 2022 – (SEAPRWire) – Black3Lab Capital, a venture capital firm built to empower web 3.0 companies with potential for global mass adoption, has announced investments in ripe web 3.0 sectors. Black3Lab’s proposed $50 to $100 million fund will focus on building a genuinely feasible economy of web 3.0-fueled…

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

BRISBANE, AUS, Aug 30, 2022 - (ACN Newswire via SEAPRWire.com) - AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm.With more than two decades of experience, AcuraBio is a globally focussed…

Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY

HONG KONG, Aug 19, 2022 - (ACN Newswire via SEAPRWire.com) - Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital.…

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

HONG KONG, Aug 15, 2022 - (ACN Newswire via SEAPRWire.com) - On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. R&G Pharmastudies publicly issued 15,000,000 shares at a price of…